SALTER LABS
Report
- Report Number
- 3000219639-2023-00027
- Event Type
- Injury
- Date Received
- September 29, 2023
- Date of Event
- August 30, 2023
- Report Date
- September 29, 2023
- Manufacturer
- SALTER LABS
- Product Code
- BZD
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- 117
Narratives
THE INCORRECT SIZES AND VARYING SHADES OF PRODUCT COULD BE THE CAUSE OF THE SKIN BREAKDOWN. THE CANNULAIDE WAS DOCUMENTED TO CAUSE SKIN DAMAGE IN NEONATAL PATIENTS UNKNOWN IF IT WAS THE CAUSE OF THE INCORRECT SIZE OR SHADE OF THE PRODUCT.
THE INCORRECT SIZES AND VARYING SHADES OF PRODUCT COULD BE THE CAUSE OF THE SKIN BREAKDOWN. THE CANNULAIDE WAS DOCUMENTED TO CAUSE SKIN DAMAGE IN NEONATAL PATIENTS UNKNOWN IF IT WAS THE CAUSE OF THE INCORRECT SIZE OR SHADE OF THE PRODUCT. COMPLAINT HISTORY REVIEWED. THERE HAVE BEEN NO SIMILAR COMPLAINTS IN THE PREVIOUS 24 MONTHS FOR CA10X PRODUCTS. BACKGROUND INFORMATION REVIEWED. NO LOT# PROVIDED. CUSTOMER HAS PURCHASED PRODUCT SEVERAL TIMES OVER THE LAST 6 MONTHS. "BAD" PRODUCT SHOWN IN PICTURE APPEARS TO BE OLDER PRODUCT, HOWEVER WITHOUT RETURNED MATERIAL OR LOT# FURTHER ASSESSMENT CANNOT BE CONDUCTED. RISK(RMA-20011): R27: PATIENT'S SKIN IS SENSITIVE TO DEVICE REMOVAL - AGE, MEDICATION, EXISTING SKIN DAMAGE, INDIVIDUAL PATIENT SENSITIVITY - S=7 O=4 RPN=28. SEE RMA-20011 NOTE 6 FOR JUSTIFICATION FOR RPN > 25.
THEY HAVE BEEN SUPPLIED CANNNULAIDE IN INCORRECT SIZES AND WITH VARYING SHADES OF PRODUCT AND SKIN BREAKDOWN. THE NEW CANNULAS ARE CAUSING SKIN BREAKDOWN FOR OUR BABIES.
THEY HAVE BEEN SUPPLIED CANNNULAIDE IN INCORRECT SIZES AND WITH VARYING SHADES OF PRODUCT AND SKIN BREAKDOWN. THE NEW CANNULAS ARE CAUSING SKIN BREAKDOWN FOR OUR BABIES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1975902 | SALTER LABS | CANNULAIDE SIZE 3, BABIES 2000G-3000G, SIZE 2, 1250G-2000G, SIZE 1, 700G-1250 | BZD | SALTER LABS | CA101-0-25,CA102-0-25,CA103-0-25 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Other |